Karima Mokhtari

Centre National de la Recherche Scientifique

Also affiliated with Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Institut du Cerveau

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial”.

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

The Lancet Oncology(2009)10.1016/s1470-2045(09)70025-7

N/A

1.3DataRank · unranked

7738 citations

Monika E. Hegi, Martin J. van den Bent, Martin JB Taphoorn, Robert C. Janzer, Samuel K. Ludwin +25 more

Identification of growth hormone receptor as a relevant target for precision medicine in low‐EGFR expressing glioblastoma

Clinical and Translational Medicine(2022)10.1002/ctm2.939

N/A

0DataRank · unranked

11 citations

Irma Segoviano Vilchis, Shai Rosenberg, Nolwenn Lemaire, Charlotte Schmitt, Jérémy Guehennec +22 more